Metformin keeps CD8+ T cells active and moving in NASH-HCC immunotherapy

Amaia Lujambio; Pablo Sarobe

doi:10.1016/j.jhep.2022.05.038

Metformin keeps CD8⁺ T cells active and moving in NASH-HCC immunotherapy

Research output: Contribution to journal › Editorial

9 Scopus citations

Original language	English
Pages (from-to)	593-595
Number of pages	3
Journal	Journal of Hepatology
Volume	77
Issue number	3
DOIs	https://doi.org/10.1016/j.jhep.2022.05.038
State	Published - Sep 2022

Access to Document

10.1016/j.jhep.2022.05.038

Cite this

@article{2ca34e32afa24918960d8dc01cc5a799,

title = "Metformin keeps CD8+ T cells active and moving in NASH-HCC immunotherapy",

author = "Amaia Lujambio and Pablo Sarobe",

note = "Funding Information: This work was funded by grants from Instituto de Salud Carlos III , Fondo Europeo de Desarrollo Regional {"}Una manera de hacer Europa{"} ( PI20/00260 ) and Gobierno de Navarra ( 54-2021 ) for PS and NIH / NCI R37CA230636 Merit Award and Damon Runyon-Rachleff Innovator Award ( DR52-18 ) for AL. ",

year = "2022",

month = sep,

doi = "10.1016/j.jhep.2022.05.038",

language = "English",

volume = "77",

pages = "593--595",

journal = "Journal of Hepatology",

issn = "0168-8278",

publisher = "Elsevier B.V.",

number = "3",

}

TY - JOUR

T1 - Metformin keeps CD8+ T cells active and moving in NASH-HCC immunotherapy

AU - Lujambio, Amaia

AU - Sarobe, Pablo

N1 - Funding Information: This work was funded by grants from Instituto de Salud Carlos III , Fondo Europeo de Desarrollo Regional "Una manera de hacer Europa" ( PI20/00260 ) and Gobierno de Navarra ( 54-2021 ) for PS and NIH / NCI R37CA230636 Merit Award and Damon Runyon-Rachleff Innovator Award ( DR52-18 ) for AL.

PY - 2022/9

Y1 - 2022/9

UR - http://www.scopus.com/inward/record.url?scp=85133381543&partnerID=8YFLogxK

U2 - 10.1016/j.jhep.2022.05.038

DO - 10.1016/j.jhep.2022.05.038

M3 - Editorial

C2 - 35714813

AN - SCOPUS:85133381543

SN - 0168-8278

VL - 77

SP - 593

EP - 595

JO - Journal of Hepatology

JF - Journal of Hepatology

IS - 3

ER -